Annual EBITDA
$1.56B$42.45M+2.79%
Summary
- Current Value
- As of today, ICLR annual EBITDA is $1.56B, up +2.79% on
- Historical Performance
- ICLR annual EBITDA is up +158.29% over the past 3 years, and up +211.41% over the past 5 years
- All-Time High Comparison
- ICLR annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ICLR annual EBITDA is +16.14% above its 3-year low of $1.35B reached on an earlier date
- Sector Comparison
- ICLR annual EBITDA is higher than 95.07% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.56B | +2.8% | +158.3% | +211.4% | +1010.2% | |
| Quarterly EBITDA | $367.90M | -7.3% | -8.0% | +178.2% | +1335.6% | |
| TTM EBITDA | $1.62B | -5.9% | +14.1% | +225.2% | +1109.2% | |
| Price | $181.38 | -17.3% | -9.8% | -15.5% | +733.5% | |
| PE Ratio | 24.52 | +6.6% | -25.3% | -28.9% | +62.3% | |
| Annual Revenue | $8.28B | +2.0% | +51.1% | +195.2% | +833.0% | |
| Annual EPS | $9.53 | +28.8% | +323.6% | +38.5% | +507.1% | |
| Annual EBIT | $1.08B | +14.9% | +270.2% | +144.1% | +893.9% | |
| Annual Net Income | $791.47M | +29.3% | +416.7% | +110.6% | +739.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.56B | at high | |
| 5Y | $1.56B | at high | |
| All | $1.56B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.35B | N/A | +16.1% |
| 5Y | $460.74M | N/A | +239.4% |
| All | $9.01M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of ICLR?
As of today, ICLR annual EBITDA is $1.56B
What is 1-year change in ICLR annual EBITDA?
ICLR annual EBITDA is up +2.79% year-over-year
What is 3-year change in ICLR annual EBITDA?
ICLR annual EBITDA is up +158.29% over the past 3 years
How far is ICLR annual EBITDA from its all-time high?
ICLR annual EBITDA is currently at its all-time high
How does ICLR annual EBITDA rank versus sector peers?
ICLR annual EBITDA is higher than 95.07% of companies in Healthcare sector
When is ICLR next annual earnings release?
The next annual earnings release for ICLR is on
Quarterly EBITDA
$367.90M$1.71M+0.47%
Summary
- Current Value
- As of today, ICLR quarterly EBITDA is $367.90M, up +0.47% on
- Historical Performance
- ICLR quarterly EBITDA is down -7.28% year-over-year, and down -7.98% over the past 3 years
- All-Time High Comparison
- ICLR quarterly EBITDA is currently -28.91% below its historical high of $517.53M set on
- 3-Year Low Comparison
- ICLR quarterly EBITDA is +0.92% above its 3-year low of $364.55M reached on an earlier date
- Sector Comparison
- ICLR quarterly EBITDA is higher than 94.03% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $367.90M | +0.5% | -7.3% | -8.0% | +178.2% | |
| Annual EBITDA | $1.56B | – | +2.8% | +158.3% | +211.4% | |
| TTM EBITDA | $1.62B | -1.8% | -5.9% | +14.1% | +225.2% | |
| Price | $181.38 | -3.4% | -17.3% | -9.8% | -15.5% | |
| PE Ratio | 24.52 | -3.4% | +6.6% | -25.3% | -28.9% | |
| Quarterly Revenue | $2.04B | +1.3% | +0.6% | +5.2% | +191.1% | |
| Quarterly EPS | $0.03 | -98.7% | -98.7% | -98.4% | -98.3% | |
| Quarterly EBIT | $258.90M | +0.0% | -11.7% | +0.4% | +138.8% | |
| Quarterly Net Income | $2.36M | -98.7% | -98.8% | -98.5% | -97.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $517.53M | N/A | -28.9% |
| 3Y | $517.53M | -28.9% | |
| 5Y | $517.53M | -28.9% | |
| All | $517.53M | -28.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $366.19M | +0.5% | |
| 3Y | $364.55M | N/A | +0.9% |
| 5Y | $137.07M | +168.4% | |
| All | -$34.32M | +1171.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ICLR?
As of today, ICLR quarterly EBITDA is $367.90M
What is ICLR quarterly EBITDA most recent change?
ICLR quarterly EBITDA was up +0.47% on September 30, 2025
What is 1-year change in ICLR quarterly EBITDA?
ICLR quarterly EBITDA is down -7.28% year-over-year
How far is ICLR quarterly EBITDA from its all-time high?
ICLR quarterly EBITDA is currently -28.91% below its historical high of $517.53M set on December 31, 2024
How does ICLR quarterly EBITDA rank versus sector peers?
ICLR quarterly EBITDA is higher than 94.03% of companies in Healthcare sector
When is ICLR next earnings release?
The next earnings release for ICLR is on
TTM EBITDA
$1.62B$28.88M-1.75%
Summary
- Current Value
- As of today, ICLR TTM EBITDA is $1.62B, down -1.75% on
- Historical Performance
- ICLR TTM EBITDA is down -5.87% year-over-year, and up +14.10% over the past 3 years
- All-Time High Comparison
- ICLR TTM EBITDA is currently -10.30% below its historical high of $1.81B set on
- 3-Year Low Comparison
- ICLR TTM EBITDA is +12.15% above its 3-year low of $1.45B reached on an earlier date
- Sector Comparison
- ICLR TTM EBITDA is higher than 94.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.62B | -1.8% | -5.9% | +14.1% | +225.2% | |
| Annual EBITDA | $1.56B | – | +2.8% | +158.3% | +211.4% | |
| Quarterly EBITDA | $367.90M | +0.5% | -7.3% | -8.0% | +178.2% | |
| Price | $181.38 | -3.4% | -17.3% | -9.8% | -15.5% | |
| PE Ratio | 24.52 | -3.4% | +6.6% | -25.3% | -28.9% | |
| TTM Revenue | $8.10B | +0.2% | -2.5% | +5.7% | +193.3% | |
| TTM EPS | $7.40 | -24.0% | -17.6% | +31.5% | +20.3% | |
| TTM EBIT | $1.13B | -2.9% | -0.9% | +35.1% | +179.8% | |
| TTM Net Income | $599.48M | -24.5% | -19.8% | +29.1% | +80.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.81B | N/A | -10.3% |
| 3Y | $1.81B | -10.3% | |
| 5Y | $1.81B | -10.3% | |
| All | $1.81B | -10.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.62B | at low | |
| 3Y | $1.45B | N/A | +12.2% |
| 5Y | $504.20M | N/A | +221.6% |
| All | -$26.31M | +6262.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ICLR?
As of today, ICLR TTM EBITDA is $1.62B
What is ICLR TTM EBITDA most recent change?
ICLR TTM EBITDA was down -1.75% on September 30, 2025
What is 1-year change in ICLR TTM EBITDA?
ICLR TTM EBITDA is down -5.87% year-over-year
How far is ICLR TTM EBITDA from its all-time high?
ICLR TTM EBITDA is currently -10.30% below its historical high of $1.81B set on December 31, 2024
How does ICLR TTM EBITDA rank versus sector peers?
ICLR TTM EBITDA is higher than 94.84% of companies in Healthcare sector
When is ICLR next earnings release?
The next earnings release for ICLR is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ICLR Official Website www.iconplc.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1060955/000162828025045879/0001628280-25-045879-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1060955/000106095525000016/0001060955-25-000016-index.htm
- ICLR Profile on Yahoo Finance finance.yahoo.com/quote/ICLR
- ICLR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iclr